UnitedHealth, Amedisys

Amedisys Stock Gains as Merger Extension Raises Hope for UnitedHealth Deal
Amedisys stock climbed Friday after the provider of home health care agreed to waive its right to terminate a merger agreement with UnitedHealth Group, bolstering expectations that the deal will succeed despite a government attempt to block it.
UnitedHealth waives deadlines for Amedisys deal
UnitedHealth Group has filed for more time to complete a $3.3 billion deal to buy Amedisys, a home health care and hospice company, after the companies agreed to waive deadlines in the face of antitrust scrutiny.
UnitedHealth, Amedisys extend deadline to close $3.3 billion deal
UnitedHealth and Amedisys have agreed to extend the deadline to close their $3.3 billion merger agreement to next year, a filing showed on Friday, as the deal faces close scrutiny from the U.S. Department of Justice.
Amedisys and UnitedHealth Extend Merger Deadline - What's Going On?
Amedisys Inc (NASDAQ:AMED) shares are trading higher on Friday after the company announced it extended its merger deadline with UnitedHealth Group Incorporated (NYSE:UNH). In an exchange filing, the companies entered into a waiver agreement,
UnitedHealth, Amedisys extend deadline for M&A deal
UnitedHealth Group's Inc.'s (NYSE: UNH) $3.3 billion acquisition of Amedisys Inc. (Nasdaq: AMED), announced in mid-2023, might not be completed until 2025 after the two companies agreed to waive a deadline for the deal.
Update: UnitedHealth, Amedisys Extend Merger Deadline Amid Regulatory Scrutiny
UnitedHealth, through its Optum subsidiary, agreed in June 2023 to acquire home health and hospice services provider Amedisys for $101 per share in cash. The deal requires
Stocks fall, Amedisys deal extension, Netflix-NFL record: Market Minute
Yahoo Finance Special Reporter Akiko Fujita breaks down Friday's top three market developments. Treasury yields are hovering near seven-month highs, with the 30-year Treasury yield (^TYX) approaching its April peak as investors anticipate a potential year-end rally.
Top Stock Movers Now: Lamb Weston, Amedisys, Supermicro, and More
Lamb Weston shares gained following reports activist investor Jana Partners took another step in its effort to force changes ...
bovnews4h
What Factors Have Led to Amedisys Inc (AMED) Stock Trading -9.09% Below Its 52-Week High?
Amedisys Inc (AMED) stock saw a modest uptick, ending the day at $89.96 which represents a slight increase of $4.01 or 4.67% from the prior close of $85.95. The stock opened at $89.5 and touched a low ...
Modern Healthcare1d
UnitedHealth, Amedisys extend window to finish $3.3B deal
UnitedHealth Group Inc. and Amedisys Inc. gave themselves more time to complete a $3.3 billion deal for the insurer to ...
5 Things to Know Before the Stock Market Opens
Stock futures are lower in pre-market trading while Treasury yields rise and Apple shares edge higher as the iPhone maker's ...
Business Insider1d
TD Cowen Remains a Hold on Amedisys (AMED)
In a report released today, Ryan Langston from TD Cowen maintained a Hold rating on Amedisys (AMED – Research Report), with a price target of $101.00. The company’s shares opened today at $89.50.
Merger Drama: UnitedHealth-Amedisys Waive Termination Rights, Face DOJ Hurdles with Extended Deal
Declared Friday UnitedHealth Group ( NYSE:UNH) and Amedisys ( NASDAQ:AMED) have waived off their rights to terminate ...